Spontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and

Giovanni Luigi De Maria1, Niket Patel2, George Kassimis2

  • 1Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals, Headley Way, Oxford OX39DU, UK ; Cardiovascular Medicine Department, Catholic University of the Sacred Heart, 00168 Rome, Italy.

Scientifica
|January 24, 2014
PubMed

Insights

Distal embolisation (DE) of atherothrombotic material from coronary plaque impairs microcirculation. This review covers spontaneous and procedural DE, focusing on diagnosis, treatment, and prevention strategies to improve patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Atherosclerosis Research

Background:

  • Atherothrombotic material detachment from coronary plaques causes microcirculation impairment.
  • Distal embolisation (DE) during percutaneous coronary intervention (PCI) is common and impacts prognosis.

Purpose of the Study:

  • To review spontaneous and procedural DE in coronary artery disease.
  • To analyze DE pathophysiology, diagnostic methods, and prevention/treatment strategies.

Main Methods:

  • Literature review of spontaneous and procedural DE.
  • Analysis of pathophysiology and diagnostic tools.
  • Evaluation of treatment and prevention strategies.

Main Results:

  • DE is an underrecognized cause of coronary microcirculation dysfunction.
  • Procedural DE during PCI has significant clinical implications.
  • Various diagnostic tools and therapeutic approaches exist for DE.

Conclusions:

  • Understanding DE is crucial for managing atherosclerotic coronary plaque.
  • Effective strategies for DE prevention and treatment are needed.
  • Further research on DE pathophysiology and management is warranted.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
659